Morepen Laboratories Limited

Morepen Laboratories Limited (MOREPENLAB) financial statements and selected valuation metrics from NSE/BSE exchange filings through 30 June 2026.

Healthcare›Healthcare›Pharmaceuticals & Biotechnology›Pharmaceuticals

morepen.com(opens the company website in a new tab)
Ask AI

Key metrics

Price as of 2026-09-03

Stock price
₹117.45
Market cap
6,431 Cr
Stock P/E
50.6
P/B
5.16
Dividend yield
0.2%

Sign in for full ratios and TTM. Learn about these metrics →

Share price

NSE closing price from historical market data.

Loading price history…

Statement tables · Consolidated

Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.

Amounts in ₹ Cr · NSE preferred when both exchanges report the same period · tap + to expand rows

Quarterly results

Quarterly · ₹ Cr · tap + rows to expand

MetricSept 2023Dec 2023Mar 2024Jun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026
Sales422 Cr445 Cr423 Cr455 Cr438 Cr453 Cr466 Cr425 Cr412 Cr484 Cr485 Cr570 Cr
Operating expenses (approx.)388 Cr394 Cr375 Cr404 Cr394 Cr417 Cr424 Cr401 Cr381 Cr438 Cr460 Cr488 Cr
EBITDA34 Cr51 Cr48 Cr52 Cr44 Cr36 Cr42 Cr24 Cr31 Cr46 Cr24 Cr83 Cr
OPM %8.0%11.4%11.4%11.3%10.1%8.0%9.1%5.7%7.5%9.6%5.0%14.5%
Other income3 Cr4 Cr4 Cr3 Cr5 Cr5 Cr5 Cr4 Cr5 Cr4 Cr8 Cr5 Cr
Interest0.46 Cr2 Cr0.80 Cr1 Cr1 Cr1 Cr5 Cr4 Cr4 Cr4 Cr4 Cr5 Cr
Depreciation8 Cr8 Cr10 Cr6 Cr2 Cr5 Cr16 Cr9 Cr11 Cr10 Cr6 Cr8 Cr
Profit before tax29 Cr44 Cr42 Cr48 Cr46 Cr35 Cr26 Cr15 Cr46 Cr35 Cr23 Cr75 Cr
Tax %25.9%27.3%32.2%24.9%24.3%24.2%21.0%27.7%10.2%22.4%32.5%24.4%
Net profit21 Cr32 Cr28 Cr36 Cr35 Cr27 Cr20 Cr11 Cr41 Cr28 Cr16 Cr56 Cr
EPS (₹)₹0.42₹0.63₹0.54₹0.71₹0.65₹0.49₹0.35₹0.20₹0.75₹0.50₹0.28₹1.03

Profit & loss (annual)

Annual · last column is TTM · ₹ Cr · tap + to expand

MetricMar 2019BSE balance sheet (this exchange's own filing had none for this period)Mar 2020BSE balance sheet (this exchange's own filing had none for this period)Mar 2021BSE balance sheet (this exchange's own filing had none for this period)Mar 2022BSE balance sheet (this exchange's own filing had none for this period)Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales769 Cr853 Cr1,188 Cr1,547 Cr1,418 Cr1,690 Cr1,812 Cr1,806 CrSign in for TTM
Operating expenses (approx.)701 Cr785 Cr1,070 Cr1,410 Cr1,338 Cr1,532 Cr1,638 Cr1,680 CrSign in for TTM
EBITDA68 Cr69 Cr119 Cr137 Cr80 Cr159 Cr174 Cr126 CrSign in for TTM
OPM %8.8%8.0%10.0%8.8%5.6%9.4%9.6%7.0%Sign in for TTM
Other income4 Cr9 Cr12 Cr10 Cr6 Cr14 Cr18 Cr21 CrSign in for TTM
Interest2 Cr2 Cr2 Cr-7 Cr2 Cr4 Cr8 Cr16 CrSign in for TTM
Depreciation40 Cr37 Cr30 Cr28 Cr28 Cr33 Cr29 Cr36 CrSign in for TTM
Profit before tax29 Cr39 Cr99 Cr127 Cr56 Cr135 Cr155 Cr119 CrSign in for TTM
Tax %1.2%14.1%1.4%19.7%30.6%28.7%23.9%20.4%Sign in for TTM
Net profit29 Cr34 Cr97 Cr102 Cr39 Cr96 Cr118 Cr95 CrSign in for TTM
EPS (₹)₹0.64₹0.75₹2.16₹2.26₹0.77₹1.88₹2.20₹1.73Sign in for TTM
Dividend payout %———0.0%0.0%0.0%0.0%11.4%Sign in for TTM
Sign in for TTM

Trailing twelve months totals and margin rows

Balance sheet

Annual · ₹ Cr · tap + rows to expand

MetricMar 2019BSE balance sheet (this exchange's own filing had none for this period)Mar 2020BSE balance sheet (this exchange's own filing had none for this period)Mar 2021BSE balance sheet (this exchange's own filing had none for this period)Mar 2022BSE balance sheet (this exchange's own filing had none for this period)Mar 2023Mar 2024Mar 2025Mar 2026
Equity capital90 Cr90 Cr90 Cr96 Cr102 Cr102 Cr110 Cr110 Cr
Reserves163 Cr194 Cr335 Cr483 Cr651 Cr745 Cr1,047 Cr1,137 Cr
Borrowings11 Cr12 Cr16 Cr19 Cr25 Cr29 Cr79 Cr195 Cr
Other liabilities352 Cr368 Cr418 Cr473 Cr333 Cr417 Cr512 Cr494 Cr
Total liabilities615 Cr663 Cr858 Cr1,070 Cr1,110 Cr1,293 Cr1,778 Cr1,936 Cr
Fixed assets (net)147 Cr134 Cr129 Cr147 Cr167 Cr213 Cr317 Cr381 Cr
CWIP0 Cr0 Cr2 Cr14 Cr17 Cr24 Cr28 Cr22 Cr
Investments0.02 Cr1 Cr1 Cr0 Cr0 Cr1 Cr85 Cr124 Cr
Loans & advances0.39 Cr0.35 Cr0.27 Cr0.34 Cr0.27 Cr0.22 Cr0.48 Cr0.46 Cr
Inventories94 Cr138 Cr175 Cr276 Cr229 Cr249 Cr300 Cr272 Cr
Trade receivables134 Cr138 Cr182 Cr251 Cr263 Cr325 Cr325 Cr333 Cr
Cash & bank10 Cr14 Cr41 Cr16 Cr22 Cr17 Cr27 Cr31 Cr
Other assets230 Cr238 Cr327 Cr367 Cr412 Cr464 Cr696 Cr773 Cr
Total assets615 Cr663 Cr858 Cr1,070 Cr1,110 Cr1,293 Cr1,778 Cr1,936 Cr

Cash flows

Annual · ₹ Cr · tap + rows to expand · last column includes FCF

MetricMar 2019BSE balance sheet (this exchange's own filing had none for this period)Mar 2020BSE balance sheet (this exchange's own filing had none for this period)Mar 2021BSE balance sheet (this exchange's own filing had none for this period)Mar 2022BSE balance sheet (this exchange's own filing had none for this period)Mar 2023Mar 2024Mar 2025Mar 2026
Cash from operating activity———-58 Cr-91 Cr73 Cr32 Cr33 Cr
Cash from investing———-32 Cr-47 Cr-83 Cr-322 Cr-123 Cr
Cash from financing———64 Cr144 Cr5 Cr300 Cr97 Cr
Net cash flow———-26 Cr6 Cr-5 Cr10 Cr7 Cr
Free cash flow (OCF − Capex)———-125 Cr-137 Cr-8 Cr-182 Cr-128 Cr

Ratios

Ratios as reported or derived per annual period.

MetricMar 2019BSE balance sheet (this exchange's own filing had none for this period)Mar 2020BSE balance sheet (this exchange's own filing had none for this period)Mar 2021BSE balance sheet (this exchange's own filing had none for this period)Mar 2022BSE balance sheet (this exchange's own filing had none for this period)Mar 2023Mar 2024Mar 2025Mar 2026
ROCE %12.4%14.5%23.6%20.0%7.4%15.8%12.9%9.4%
ROE %0.0%0.0%22.9%20.7%5.1%0.0%0.0%0.0%
Debtor days6359565968706567
Inventory days10012210312610710310995
Days payable178152123118106122132111
Cash conversion cycle-1529366769514251
Debt / equity0.040.000.040.030.030.030.070.16
Current ratio0.881.061.301.612.352.212.322.37
Net debt / EBITDA0.000.000.000.000.040.080.301.30

Compare with peers

Loading peers…